Toxic effect of C60 fullerene-doxorubicin complex towards tumor and normal cells in vitro

Biopolymers and Cell

Volumn 30, Issue 5, 2014, Pages 372-376

  Prylutska, S V ^a   Didenko, G V ^b   Potebnya, G P ^b   Bogutska, K I ^a   Prylutskyy, Yu I ^a   Ritter, U ^c   Scharff, P ^c  

^a TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^c ILMENAU UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

C60 fullerene doxorubicin complex; Cytotoxicity; Dynamic light scattering; MTT assay; Normal and tumor cells

Indexed keywords

ANTINEOPLASTIC AGENT; C60 FULLERENE; DOXORUBICIN; DOXORUBICIN C60 FULLERENE; FULLERENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; EHRLICH ASCITES TUMOR; HYDRODYNAMICS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LEUKEMIA L 1210; LEWIS CARCINOMA; LIGHT SCATTERING; LIVER CELL; LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; MTT ASSAY; NONHUMAN; SCANNING PROBE MICROSCOPY; SPECTRAL SENSITIVITY; SPECTROPHOTOMETER; TUMOR CELL;

EID: 84908506546     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.0008B4     Document Type: Article

References (25)

1. Anilkumar P, Lu F, Cao L, et al. Fullerenes for applications in biology and medicine. Curr Med Chem. 2011;18(14):2045–59
2. Darwish AD. Fullerenes. Annu Rep Prog Chem, Sect A: Inorg Chem. 2012;108:464–77
3. Gharbi N, Pressac M, Hadchouel M, et al. [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005;5(12):2578–85
4. Prylutska SV, Grynyuk II, Matyshevska OP, et al. Anti-oxidant properties of C60 Fullerenes in vitro. Fullerenes Nanotubes Carbon Nanostruct. 2008; 16(5–6):698–705
5. Scharff P, Ritter U, Matyshevska OP, et al. Therapeutic reactive oxygen generation. Tumori. 2008;94(2):278–83
6. 60 compound with a model bimolecular lipid membrane. Mater Sci Engineer C. 2011; 31(5): 1148–50
7. 60 increase the specific conductivity and capacity of lipid model membrane and form the channels in cellular plasma membrane. J Biomed Nanotechnol. 2012;8(3):522–7
8. Prylutska SV, Burlaka AP, Klymenko PP, et al. Using water-soluble C60 fullerenes in anticancer therapy. Cancer Nano. 2011; 2:105–10
9. Prylutska SV, Burlaka AP, Prylutskyy YI et al. Pristine C60 fullerenes inhibit the rate of tumor growth and metastasis. Exp Oncol. 2011;33(3):162–4
10. Lucafo M, Pelillo C, Carini M, et al. A cationic [60] fullerene derivative reduces invasion and migration of HT-29 CRC cells in vitro at dose free of significant effects on cell survival. Nano- Micro Lett. 2014; 6(2):163–8
11. Aschberger K, Johnston HJ, Stone V, et al. Review of fullerene toxicity and exposure – appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol. 2010; 58(3):455–73
12. Andrievsky G, Klochkov V, Derevyanchenko L. Is the C60 fullerene molecule toxic?!. Fullerenes Nanotubes Carbon Nanostruct. 2005; 13(4):363–76
13. 60 and carbon nanotubes in thymus cells. Materwiss Werksttech. 2009;40(4):238–41
14. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA. Fullerenebased amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro. 2006;20(8):1313–20
15. Hrelia S, Fiorentini D, Maraldi T, et al. Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim Biophys Acta. 2002; 1567(1–2):150–6
16. Menna P, Paz OG, Chello M, et al. Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2012;11 Suppl 1:S21–36
17. 60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials. 2009;30 (6):1184–96
18. Evstigneev MP, Buchelnikov AS, Voronin DP, et al. Complexation of C60 fullerene with aromatic drugs. PhysChemPhys. 2013; 14(3):568–78
19. Liu JH, Cao L, Luo PG, et al. Fullerene-conjugated doxorubicin in cells. ACS Appl Mater Interfaces. 2010;2(5):1384–9
20. 60 fullerene on the in vitro action of aromatic drug molecules. Eur Biophys J. 2014;43(6–7):265–76
21. 60 fullerene solubility in aqueous solution. Langmuir. 2014;30 (14):3967–70
22. Ritter U, Prylutskyy YI, Evstigneev MP, et al. Structural features of highly stable reproducible C60 fullerene aqueous colloid solution probes by various techniques. Fullerenes Nanotubes Carbon Nanostruct. 2015; 23(6):530–4
23. Prylutskyy YI, Buchelnikov AS, Voronin DP, et al. C60 fullerene aggregation in aqueous solution. Phys Chem Chem Phys. 2013; 15(23):9351–60
24. Sashchenko LP, Lukyanova TI, Kabanova OD, et al. Different pathways of the release of cytotoxic proteins in LAK cells. Immunol Lett. 1996;53(1):25–9
25. Carmichael J, Mitchell JB, DeGraff WG, et al. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br J Cancer. 1988;57(6):540–7.